ARCHIVES

In Brief: Sharp Won’t Take MIT Presidency; Brow returns To NCI; Goldman Succeeds Lawrence At MCV

This article is from The Cancer Letter archive.

Vol. 16 No. 10 | March 9, 1990

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

May 30, 2003

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

September 15, 1995

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997

In Brief: Weldon Gage named CFO at MD Anderson Cancer Center

December 12, 2014